Provocholine
FDA Approves Breo Ellipta to Treat COPD »
"The U.S. Food and Drug Administration today approved Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary di"...
Provocholine
PATIENT INFORMATION
To assure the safe and effective use of Provocholine® (methacholine chloride) inhalation challenge, the following instructions and information should be given to patients:
Patients should be instructed regarding symptoms that may occur as a result of the test and how such symptoms can be managed.
A female patient should inform her physician if she is pregnant, or the date of her last onset of menses, or the date and result of her last pregnancy test. (See PRECAUTIONS: Pregnancy.)
Last reviewed on RxList: 9/25/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Provocholine Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
